Latest Breaking News On - Financial planning analysis at agios pharmaceuticals - Page 1 : comparemela.com

Published: May 05, 2021     CAMBRIDGE, Mass. (BUSINESS WIRE) Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform, today announced that Elizabeth Radcliffe has joined the company as Chief Financial Officer. She is a strategic business leader with deep experience managing finance and planning across the full range of biopharmaceutical R&D, commercial and business operations, including leadership roles at Arrakis Therapeutics, Agios Pharmaceuticals, and Biogen. Ms. Radcliffe joins Affinivax at a pivotal time as the company evolves its vaccine pipeline and expands its operations.

United statesUnited kingdomHarvard universitySteven bruggerElizabeth radcliffeYale universityExcelon corporationParthenon groupAgios pharmaceuticalsMelinda gates foundationAffinivax incFinancial planning analysis at agios pharmaceuticalsSloan school of managementBusiness developmentMultiple antigen presenting systemChief financial